← Eichor
Study identifier: NCT05578586 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Pilot Study for Optimizing Meropenem Administration in the ICU

Condition: Drug Effect  ·  Sponsor: Oslo University Hospital

PhaseNA
Planned participants50
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Can antibiotic drugs be administered faster and make acceptable serum concentrations if we give short but multiple infusions compared to long and fewer infusions? In this study we will compare giving meropenem 1 gram 6 times daily in 15 minutes infusions to the recommended 2 gram 3 times daily in 3 hours infusions. In patients in the intensive care unit, the need for intravenous access is of essence. If 6 short infusions results in the same serum concentrations as 3 long infusions, we will increase intravenous access from 15 to 22.5 hours daily.

This description comes directly from the study's public registry record.

Talk to the study team

Ingvild Nordøy, PhD  ·  +4793028084  ·  inordoy@ous-hf.no

Trine Kåsine, PhD  ·  +4790779669  ·  trikaa@ous-hf.no

Always discuss trial participation with your own doctor first.

Locations (1)

Oslo University HospitalOslo, NorwayRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05578586